← Back to news
S

Seeking Alpha: News

ARS Pharma gains FDA clearance to remove age restriction from neffy

S

Neuberger Berman Energy Infrastructure and Income Fund raises dividend by 20% to $0.0701

S

Fundstrat Granny Shots US Large Cap & Income ETF declares $0.1595 dividend

S

Southland Holdings GAAP EPS of -$4.00 misses by $3.82, revenue of $104M misses by $108.12M

S

enVVeno Medical GAAP EPS of -$33.06

S

Wix.com downgraded to Underweight at JP Morgan on core business concerns

B

Kopin reports Q4 results

B

OnKure Therapeutics prices $150M oversubscribed private placement

B

Teleflex says Irenic falsely claimed company was not open for buyout offers

B

Humacyte GAAP EPS of -$0.13 in-line, revenue of $0.47M misses by $0.88M

B

Boeing wins $326M U.S. Army defense contract for CH-47F helicopters

B

The Metals Company GAAP EPS of -$0.08

B

Vor Bio announces $75M private placement

B

SAP announces deal to acquire Reltio

B

Precision Optics prices upsized $10M public stock offering

B

X moves 'TweetDeck' to its $40 monthly plan without a heads-up

B

The Rivian-Volkswagen joint venture passes a key software milestone

B

Senti Biosciences Non-GAAP EPS of -$0.53 misses by $0.06

B

Infracap Small Cap Income ETF raises dividend by 2.1% to $0.245

B

Argan stock surges 10% after strong Q4 & FY26 earnings beat; guidance tops estimates

B

51Talk Online Education Group reports Q4 results

B

Stingray Group Inc. declares $0.085 dividend

B

Clarke enters agreement of $1.1B to acquire Ravelin

B

4 stocks to watch on Friday: MU, TGT, AAPL, META

B

Bessent denies FT report on BoE-style Fed oversight

S

Length of Iran war in focus as Nasdaq falls into correction territory

S

Alight receives NYSE noncompliance notice

S

Glow Lifetech reduces over 41M warrants, 5M options

S

Kanzhun continues share repurchase program

S

AstraZeneca succeeds in two Phase 3 trials for COPD therapy

S

SoftBank secures $40B loan for OpenAI investment, other purposes

S

SSR Mining gets TSX approval for share buyback of up to 21.5M shares

S

High spirits: Analysts weigh in on Brown-Forman's potential deal with Pernod Ricard

S

Novo Nordisk wins FDA approval for once-weekly insulin

S

Satellos Bioscience GAAP EPS of -$1.70

S

Legence GAAP EPS of -$0.55 misses by $0.59, revenue of $737.64M beats by $118.33M

S

Instil Bio Non-GAAP EPS of -$0.97 beats by $2.81

S

Werewolf Therapeutics GAAP EPS of -$0.20 beats by $0.14

S

Autolus Therapeutics GAAP EPS of -$0.34 misses by $0.07, revenue of $24.29M beats by $0.37M

S

BioXcel Therapeutics GAAP EPS of -$0.58 beats by $0.06, revenue of $0.26M beats by $0.11M

S

Western Copper and Gold reports FY results

S

Meitu, Inc. GAAP EPS of ¥0.12, revenue of ¥3.85B

S

Seabridge Gold GAAP EPS of -$0.53

S

SBC Medical Group GAAP EPS of $0.14 beats by $0.03, revenue of $39.57M misses by $5.87M

S

Rocket Pharma wins FDA nod for gene therapy (update)

S

American Airlines said to be in talks with Starlink, Amazon Leo for in-flight Wi-Fi

S

SANUWAVE Health reports Q4 results; gives Q1 and FY outlook

S

The Las Vegas Strip breaks its gaming win losing streak in February

S

Hotel bookings in World Cup cities are below expectations

S

TravelSky Technology GAAP EPS of ¥0.80, revenue of ¥8.77M

S